Abeona Therapeutics Inc. financial data

Symbol
ABEO on Nasdaq
Location
6555 Carnegie Ave, 4 Th Floor, Cleveland, OH
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 14, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 610 % +0.94%
Debt-to-equity 95.1 % -59.5%
Return On Equity 77.7 %
Return On Assets 39.8 %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 51.3M shares +18.4%
Common Stock, Shares, Outstanding 51.2M shares +23%
Entity Public Float 171M USD +118%
Common Stock, Value, Issued 512K USD +22.8%
Weighted Average Number of Shares Outstanding, Basic 52.5M shares +31.3%
Weighted Average Number of Shares Outstanding, Diluted 66.6M shares +30.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 400K USD
Research and Development Expense 33.8M USD +9.26%
General and Administrative Expense 32.5M USD +46.9%
Operating Income (Loss) -74.5M USD -31.4%
Nonoperating Income (Expense) 1.04M USD +46%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 124M USD +1579%
Income Tax Expense (Benefit) 15.5M USD
Net Income (Loss) Attributable to Parent 57.2M USD +1370%
Earnings Per Share, Basic 1 USD/shares +989%
Earnings Per Share, Diluted 1 USD/shares

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 164M USD +375%
Cash, Cash Equivalents, and Short-term Investments 84.5M USD +34.8%
Accounts Receivable, after Allowance for Credit Loss, Current 3.5M USD +250%
Inventory, Net 2.69M USD
Assets, Current 232M USD +84.5%
Property, Plant and Equipment, Net 9.49M USD +139%
Operating Lease, Right-of-Use Asset 4.14M USD +2.98%
Other Assets, Noncurrent 338K USD +238%
Assets 246M USD +83.8%
Accounts Payable, Current 7.34M USD +137%
Accrued Liabilities, Current 5.5M USD +11.6%
Liabilities, Current 34.5M USD +105%
Operating Lease, Liability, Noncurrent 3.98M USD +31.8%
Liabilities 82.7M USD +36%
Accumulated Other Comprehensive Income (Loss), Net of Tax -45K USD +66.4%
Retained Earnings (Accumulated Deficit) -716M USD +7.4%
Stockholders' Equity Attributable to Parent 164M USD +123%
Liabilities and Equity 246M USD +83.8%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -18.4M USD -26.6%
Net Cash Provided by (Used in) Financing Activities 6.77M USD -73.4%
Net Cash Provided by (Used in) Investing Activities 4.21M USD
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 51.2M shares +23%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect -7.42M USD -341%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 164M USD +371%
Interest Paid, Excluding Capitalized Interest, Operating Activities 675K USD +11.2%
Deferred Tax Assets, Valuation Allowance 114M USD +4.97%
Deferred Tax Assets, Gross 114M USD +4.97%
Operating Lease, Liability 4.52M USD -6.13%
Depreciation 700K USD -12.5%
Payments to Acquire Property, Plant, and Equipment 1.4M USD +93.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 57.3M USD +1360%
Lessee, Operating Lease, Liability, to be Paid 5.84M USD -0.15%
Property, Plant and Equipment, Gross 25.5M USD +42.4%
Operating Lease, Liability, Current 537K USD -70%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.15M USD +44.9%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.1M USD +29.2%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +13.9%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 1.33M USD +27.4%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.17M USD +45.2%
Deferred Tax Assets, Operating Loss Carryforwards 88.1M USD +11.9%
Preferred Stock, Shares Issued 0 shares
Current Income Tax Expense (Benefit) 15.5M USD
Preferred Stock, Shares Authorized 2M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.2M USD +45.7%
Additional Paid in Capital 880M USD +3.89%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 534K USD +8.76%
Share-based Payment Arrangement, Expense 9.29M USD +56.4%
Interest Expense 4.14M USD +84.9%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%